Public Health Politics: Who’s Really in Charge?

The recent shake‑up of U.S. health advisory bodies shows how politics can overtake science.

June 2025: A Sudden Dismissal

• The Secretary of Health and Human Services abruptly dismissed every member of the long‑standing CDC advisory panel that guides vaccine policy.
• The decision was announced in a newspaper op‑ed, not through official channels.
• Stated reason: conflicts of interest—contradicted by independent studies showing those experts had low or properly managed conflicts.
• The real motive appears to have been political control, keeping the panel out of reach until a new administration could appoint its own allies.

Replacement and Ideological Shift

• Within days, replacements were hand‑picked.
• Many had histories of vaccine skepticism or ties to groups that challenge mainstream science.
• A cardiologist claimed COVID shots raise heart‑attack risk.
• A pharmacist was linked to a faith‑based health system.
• The panel’s makeup shifted from balanced expertise to an ideological front, with little regard for the original charter that required scientific competence.

Legal Repercussions and Charter Rewrite

• Former CDC chief medical officer Dr. Debra Houry resigned in protest, revealing that new nominees had never completed required ethics forms.
• A federal judge later ruled most appointments illegal, citing that only a minority had genuine vaccine knowledge.
• Instead of correcting the panel, the administration rewrote its own charter to remove the expertise requirement, making it easier to sidestep future lawsuits.

Broader Pattern of Disbandment

• An audit found that nearly a quarter of HHS advisory committees were disbanded in 2025 without scientific justification.
• Committees on autism, preventive services, and other areas saw members with strong anti‑vaccine views or political leanings replace qualified scientists.
• The changes often followed accusations of being “too woke,” a coded phrase for supporting health equity.

Targeting Peptide Drugs

• The Secretary publicly endorses untested compounds like BPC‑157 and TB‑500, claiming the FDA suppresses them.
• FDA scientists have repeatedly found insufficient evidence for their safety or efficacy.
• A new advisory committee, largely composed of individuals who sell these peptides or run wellness clinics, voted to lift restrictions on several peptides, aligning with the Secretary’s agenda.

The Cycle and Its Risks

• Remove independent scientific voices.
• Replace them with politically aligned allies.
• Alter rules to protect the new order.

This undermines the purpose of advisory committees—to shield public health from partisan bias—and risks misinforming citizens. Vigilance is needed now, before decisions lead to harm.